search
Back to results

Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9

Primary Purpose

Cocaine-Related Disorders, Substance-Related Disorders

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Cocaine-Related Disorders
Sponsored by
National Institute on Drug Abuse (NIDA)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Cocaine-Related Disorders

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria: Cocaine dependence. Seeking residential treatment.

Sites / Locations

  • New York MDRU

Outcomes

Primary Outcome Measures

Identification of homogenous subgroups within total population of cocaine dependent adults

Secondary Outcome Measures

Full Information

First Posted
April 18, 2001
Last Updated
January 11, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
New York MDRU
search

1. Study Identification

Unique Protocol Identification Number
NCT00015275
Brief Title
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
Official Title
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence
Study Type
Interventional

2. Study Status

Record Verification Date
December 2002
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
New York MDRU

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to define pathophysiological subtypes of abnormalities in subjects with cocaine dependence.
Detailed Description
The objective of this study is to define subgroups of patients with differential treatment outcome on the basis of differential baseline electrophysiological clusters.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders, Substance-Related Disorders

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Phase 4
Masking
None (Open Label)
Enrollment
0 (false)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Cocaine-Related Disorders
Primary Outcome Measure Information:
Title
Identification of homogenous subgroups within total population of cocaine dependent adults

10. Eligibility

Sex
Male
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Cocaine dependence. Seeking residential treatment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Rotrosen, M.D.
Organizational Affiliation
New York MDRU
Official's Role
Principal Investigator
Facility Information:
Facility Name
New York MDRU
City
New York
State/Province
New York
ZIP/Postal Code
10010
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9

We'll reach out to this number within 24 hrs